Chardan Capital Markets Raises Price Target on Amicus Therapeutics (FOLD); Reiterates Buy

November 29, 2016 8:31 AM EST Send to a Friend
Chardan Capital Markets reiterated a Buy rating on Amicus Therapeutics (NASDAQ: FOLD), and raised the price target to $16.00 (from ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login